DNAnexus and Discovery Life Sciences to Streamline Precision Health Data Analysis | Discovery Life Sciences Announces New CEO | Discovery Life Sciences Announces Major Strategic Expansions: New State-of-the-Art Facilities, Advanced Technologies, and Global Brand Enhancements | Discovery Life Sciences expands high-throughput proteomics services |

Biospecimens & Biomarker Testing for Precision Oncology Programs

Your breakthrough cancer research begins with diverse and well-characterized biospecimens. Discovery Life Sciences has an extensive inventory of human cancer samples, CLIA/CAP-certified service laboratories, and a team of experts dedicated to your cause.

Better Cancer Biospecimens for Better Patient Outcomes

The cure is out there, and it starts with you and the biospecimens powering your research. Explore our diverse range of highly characterized human cancer biospecimens for your precision oncology program.

FFPE

Cell and gene therapy is transforming what’s possible with cancer research and treatment – but only with reliable, high-quality cellular starting materials and appropriate process analytics. Get both from Discovery and AllCells.

DTC

Diseased and benign dissociated tissue and tumor cells (DTCs).

Biofluids

Blood-based biospecimens, including fresh whole blood, double-spun plasma, serum, buffy coat, cord blood and bone marrow.

Matched Sets

Matched donor biospecimen sets across various biospecimen formats.

Biofluids (Other)

Non-blood biofluid biospecimens, including urine, saliva, aspirate, cerebrospinal fluid (CSF), oral swab, bronchoalveolar lavage (BAL), nasal fluid, synovial fluid, sputum and other biofluid biospecimens.

BMMCs

Diseased and healthy bone marrow mononuclear cells (BMMCs) with flow cytometric immunophenotypic data available.

Immune Cell Isolations

Isolated immune cells from healthy donors, all tested for viruses like HIV, HBV, HCV, and CMV.

Normal (Controls)

Highly characterized human cellular starting materials with 2,800+ recallable donors – paired with world-class genomics and flow cytometry labs.

Revolutionize Cancer Research with Cell & Gene Therapy

Further Characterize Cancer Biospecimens (Yours or Ours)

We provide deeper multiomic biomarker analyses to further characterize biospecimens from our inventory or your studies.

GENOMIC BIOMARKERS

HudsonAlpha Discovery
Whole genome sequencing
Whole exome sequencing
Targeted panels
Long-read sequencing
RNASeq
Single cell sequencing

PATHOLOGY-GUIDED TISSUE BIOMARKERS

Multiplexed and singleplex IHC
In-situ hybridization
RNAScope
Digital pathology and image analysis
PCR
Immunoflourescence
Colorimetric

CELL-BASED BIOMARKERS

HudsonAlpha Discovery
Whole genome sequencing
Whole exome sequencing
Targeted panels
Long-read sequencing
RNASeq
Single cell sequencing

Biospecimens & Biomarker Testing for Precision Oncology Programs

Better Cancer Biospecimens for Better Patient Outcomes

FFPE

DTC

Biofluids

Matched Sets

Biofluids (Other)

BMMCs

Immune Cell Isolations

Normal (Controls)

Revolutionize Cancer Research with Cell & Gene Therapy

Further Characterize Cancer Biospecimens (Yours or Ours)

Oncology Reading & Resources for You

An Assay Platform to Evaluate Cytokine Secretion & T Cell Activation

eBooks

Tell Us About Your Oncology Project’s Needs

April 2024

May 2024

MARKETS WE SERVE

COMPANY

Markets We Serve

Resources

Popular Keywords

Categories,Pages

Quick Links

Technologies

Development and Clinical Trial Solutions

Tissues

Technologies

Development and ClinicalTrial Solutions

Development and Clinical
Trial Solutions

Development and Clinical
Trial Solutions